The question is not whether sub-nanometer semiconductor research matters. It plainly does. IBM has announced transistor technology at the sub-1 nanometer scale, described as nanostack transistors and presented as the first technology of its kind at that scale. If that line of research matures, it could change chip performance and energy efficiency, two metrics that shape everything from data centers and consumer devices to military systems and hospital infrastructure. The real policy question is narrower and more serious: should governments provide increased funding for this research and development, and under what terms?
My answer is yes, but not on the naive theory that every frontier technology should simply be accelerated because it is exciting, strategic, or potentially profitable. Governments should increase funding for sub-nanometer semiconductor R&D because semiconductors are foundational infrastructure. They are too important to leave entirely to corporate time horizons and private risk appetites. But public money must come with public obligations. The right case for increased funding is not a race-to-the-bottom competitiveness slogan. It is a duty-of-care argument about resilient innovation.
The strongest pro-funding arguments from the debate were not frivolous. One side correctly observed that sub-nanometer work is high-risk, capital-intensive, and long-horizon. A private company can produce a headline-grabbing breakthrough, as IBM has done, without proving that the market alone will carry the field from laboratory promise to robust, secure, socially beneficial deployment. Basic and pre-competitive semiconductor research often creates spillover benefits that no single firm can fully capture. That is a textbook reason governments fund science. Better chips and lower energy use would not merely enrich one balance sheet. They could improve national productivity, reduce power demand in compute-heavy systems, and strengthen supply-chain resilience in a world where semiconductors underpin almost every critical sector.
That is the best argument for increased government funding, and it should be taken seriously. The public has a valid interest in supporting research that private actors may underfund, especially when the output becomes part of national and economic infrastructure.
The strongest anti-funding argument also deserves more respect than it often gets. Critics are right that IBM's breakthrough is itself evidence that private firms remain capable of pioneering advanced semiconductor technology. They are also right to warn that government money can distort incentives, reward incumbents, and convert vibrant research ecosystems into compliance-driven subsidy channels. There is a real danger in treating every private announcement as proof of market failure. There is also a real danger in funneling money into politically favored labs or firms without measurable public benefit. If increased funding simply becomes corporate welfare for companies already positioned to spend, the public will have socialized risk while privatizing reward.
This is exactly why the resolution should be supported through a regulatory framework, not despite one.
The debate's shallow version asked whether we should choose between speed and caution. That is the wrong frame. The better frame is whether we want public funding to accelerate a trusted semiconductor base or merely a faster one. Sub-nanometer transistors are not a novelty app. They are part of the future substrate of computation. When governments subsidize the substrate, they assume responsibility for foreseeable harms associated with how it is developed and integrated.
Those harms are not speculative in the abstract. The smaller, denser, and more complex chip architectures become, the more they can amplify systemic dependencies. A breakthrough in transistor scaling can ripple through cloud infrastructure, defense electronics, industrial automation, and AI hardware. If public funding pushes rapid advancement without corresponding investment in verification, security testing, supply-chain integrity, and energy claims validation, then the state is not acting as a steward. It is acting as an accelerant.
This is where the precautionary principle is often misunderstood. It does not mean paralysis. It means the burden of proof lies on those who want to remove protections or dismiss foreseeable risks as the price of progress. In this case, increased funding is justified precisely because governments can attach conditions the market often will not voluntarily impose. If taxpayers fund sub-nanometer semiconductor R&D, governments should require open research standards where appropriate, strong cybersecurity protocols, independent evaluation of performance and energy-efficiency claims, conflict-of-interest safeguards, and diversified grantmaking that avoids overconcentration in a handful of incumbent winners.
In other words, funding should buy capacity and accountability.
This is where my framework diverges from the simpler national competitiveness argument advanced in the debate. Competitiveness matters. So does avoiding dependency on foreign research ecosystems or brittle supply chains. But competitiveness is not a sufficient governing principle for foundational technology policy. History is littered with strategic sectors where the language of urgency became an excuse for opaque subsidies, weak oversight, and public capture by private actors. Move fast is not a defense when the object being moved is critical infrastructure.
Nor is it enough to say that because semiconductors matter, any increase in funding is automatically wise. Public semiconductor investment should be structured to preserve pluralism in the research ecosystem. That means funding universities, public-interest labs, standards work, materials science, metrology, and multiple technical pathways, not merely writing larger checks to whichever firm produces the most compelling press release. IBM's nanostack announcement is important, but no government should confuse first announcement with sole roadmap. The state should expand the option set, reduce systemic blind spots, and build the conditions for independent scrutiny.
A careful reader may object that these guardrails could slow down innovation. Sometimes they will. That is not a defect. The asymmetry here matters. A modest delay in commercializing a more efficient chip is usually recoverable. A preventable security weakness or fragile supply dependency embedded into next-generation compute infrastructure can be far more costly and difficult to unwind. The public interest is not served by being first to scale a technology if that scaling locks in avoidable vulnerabilities.
So the right policy is not simply increased government funding for sub-nanometer semiconductor research and development. It is increased funding tied to public-interest conditions. Fund the science because the science is consequential, risky, and too foundational to leave solely to market timing. But attach requirements that reflect semiconductors' role as critical infrastructure: transparency where feasible, rigorous testing, broad participation, supply-chain due diligence, and periodic review of whether funded research is actually advancing secure performance and genuine energy efficiency rather than hype.
That is the durable lesson of this debate. The choice was never between state action and market innovation. The real choice is between public investment with discipline and public investment without it. On a technology as consequential as sub-1 nanometer semiconductors, only the first choice meets the government's duty of care.
Governments should increase funding. They should also regulate the terms of that increase with enough seriousness to deserve public trust. Anything less would confuse ambition with stewardship.